Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression

In order to determine whether klotho is involved in the therapeutic effects of Astragaloside-IV on bradycardia, we evaluated the effect of ASG-IV on klotho and the effect of klotho on HCN4 and If. Administrating isoproterenol (5mg/kg) for 15days to establish a rat bradycardia model randomized SD rats into control, model (ISO) and ASG-IV (5mg/kg/day) groups to explore the effect of ASG-IV on klotho. Rats were sacrificed on day15 after heart rate and heart function were measured; SAN tissues were collected to measure the expression of klotho and HCN4. In vitro, neonatal rat myocardial cells were incubated with LPS for 24h to inhibit the expression of HCN4 and incubated with LPS+ klotho to explore the effect of klotho on HCN4 expression. We also adopted full-patch-clamp technique to explore the effect of klotho on If. Heart rate in model group was significantly decreased (356.6±19.7 vs. 428.9±19.9 in control group, P